Search

Margaret Page

Examiner (ID: 19318)

Most Active Art Unit
1206
Art Unit(s)
1208, 1206
Total Applications
230
Issued Applications
179
Pending Applications
3
Abandoned Applications
48

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16837963 [patent_doc_number] => 20210145975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => IMMUNOGENIC COMPOUND [patent_app_type] => utility [patent_app_number] => 17/091106 [patent_app_country] => US [patent_app_date] => 2020-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091106 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/091106
IMMUNOGENIC COMPOUND Nov 5, 2020 Abandoned
Array ( [id] => 16655942 [patent_doc_number] => 20210052578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => TREATMENT OF DISEASES [patent_app_type] => utility [patent_app_number] => 17/090673 [patent_app_country] => US [patent_app_date] => 2020-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14400 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 342 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090673 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/090673
TREATMENT OF DISEASES Nov 4, 2020 Abandoned
Array ( [id] => 18160049 [patent_doc_number] => 20230026641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID [patent_app_type] => utility [patent_app_number] => 17/773734 [patent_app_country] => US [patent_app_date] => 2020-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30679 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773734 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/773734
Method for producing peptide compound comprising highly sterically hindered amino acid Nov 4, 2020 Issued
Array ( [id] => 16853561 [patent_doc_number] => 20210154306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => DEGRADABLE THIOL-ENE POLYMERS AND METHODS OF MAKING THEREOF [patent_app_type] => utility [patent_app_number] => 17/085798 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40808 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085798 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085798
Degradable thiol-ene polymers and methods of making thereof Oct 29, 2020 Issued
Array ( [id] => 16915809 [patent_doc_number] => 20210188901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS [patent_app_type] => utility [patent_app_number] => 17/086196 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086196 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/086196
SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS Oct 29, 2020 Abandoned
Array ( [id] => 19931730 [patent_doc_number] => 12304927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => De novo design of protein switches [patent_app_type] => utility [patent_app_number] => 17/077692 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 37 [patent_no_of_words] => 19845 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077692 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/077692
De novo design of protein switches Oct 21, 2020 Issued
Array ( [id] => 17490448 [patent_doc_number] => 11279737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-22 [patent_title] => Antimicrobial peptide variants and uses thereof [patent_app_type] => utility [patent_app_number] => 17/072968 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4813 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072968 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/072968
Antimicrobial peptide variants and uses thereof Oct 15, 2020 Issued
Array ( [id] => 16621517 [patent_doc_number] => 20210040170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => GLYCO-MODIFIED ATRIAL NATRIURETIC PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/071973 [patent_app_country] => US [patent_app_date] => 2020-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071973 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/071973
GLYCO-MODIFIED ATRIAL NATRIURETIC PEPTIDE Oct 14, 2020 Abandoned
Array ( [id] => 18483700 [patent_doc_number] => 20230211003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => CONJUGATE COMPOUNDS FOR PREVENTING AND/OR TREATING HBV AND/OR HDV INFECTIONS, LIVER DISEASES ANDFOR TARGETING NTCP [patent_app_type] => utility [patent_app_number] => 17/767880 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767880 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767880
CONJUGATE COMPOUNDS FOR PREVENTING AND/OR TREATING HBV AND/OR HDV INFECTIONS, LIVER DISEASES ANDFOR TARGETING NTCP Oct 8, 2020 Pending
Array ( [id] => 18019055 [patent_doc_number] => 20220370554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => Calreticulin for Treating or Preventing an Angiogenic Eye Disease [patent_app_type] => utility [patent_app_number] => 17/767232 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767232 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/767232
Calreticulin for Treating or Preventing an Angiogenic Eye Disease Oct 6, 2020 Pending
Array ( [id] => 17981039 [patent_doc_number] => 20220347075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN AND ITS APPENDAGES [patent_app_type] => utility [patent_app_number] => 17/765707 [patent_app_country] => US [patent_app_date] => 2020-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765707 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765707
PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN AND ITS APPENDAGES Oct 5, 2020 Pending
Array ( [id] => 18284590 [patent_doc_number] => 20230100062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => ANTIMICROBIAL PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/765976 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765976 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765976
ANTIMICROBIAL PEPTIDES Oct 4, 2020 Abandoned
Array ( [id] => 16596655 [patent_doc_number] => 20210023186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => POLYMER FACTOR IX MOIETY CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/063654 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20420 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063654 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063654
POLYMER FACTOR IX MOIETY CONJUGATES Oct 4, 2020 Abandoned
Array ( [id] => 17177254 [patent_doc_number] => 11154482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-26 [patent_title] => Peptide, composition and method for anti-hair graying [patent_app_type] => utility [patent_app_number] => 17/036529 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2514 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036529 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/036529
Peptide, composition and method for anti-hair graying Sep 28, 2020 Issued
Array ( [id] => 18036199 [patent_doc_number] => 20220380414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTS [patent_app_type] => utility [patent_app_number] => 17/762333 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/762333
COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTS Sep 22, 2020 Pending
Array ( [id] => 18058072 [patent_doc_number] => 20220389158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => DMSO-Free Synthesis of Oligopeptide-Modified Poly(Beta-Amino Ester)s and Their Use in Nanoparticle Delivery Systems [patent_app_type] => utility [patent_app_number] => 17/762133 [patent_app_country] => US [patent_app_date] => 2020-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762133 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/762133
DMSO-Free Synthesis of Oligopeptide-Modified Poly(Beta-Amino Ester)s and Their Use in Nanoparticle Delivery Systems Sep 20, 2020 Pending
Array ( [id] => 18451521 [patent_doc_number] => 20230192799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CNP Variants and Conjugates Thereof [patent_app_type] => utility [patent_app_number] => 17/642150 [patent_app_country] => US [patent_app_date] => 2020-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642150 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/642150
CNP Variants and Conjugates Thereof Sep 15, 2020 Pending
Array ( [id] => 18003560 [patent_doc_number] => 20220362326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE MYOCARDIAL INFARCTION [patent_app_type] => utility [patent_app_number] => 17/642936 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642936 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/642936
INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE MYOCARDIAL INFARCTION Sep 10, 2020 Abandoned
Array ( [id] => 17960062 [patent_doc_number] => 20220340642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => DCR3 VARIANT [patent_app_type] => utility [patent_app_number] => 17/642485 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642485 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/642485
DCR3 VARIANT Sep 10, 2020 Pending
Array ( [id] => 18590279 [patent_doc_number] => 11739162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-29 [patent_title] => Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials [patent_app_type] => utility [patent_app_number] => 17/015532 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 90 [patent_no_of_words] => 17272 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015532 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/015532
Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials Sep 8, 2020 Issued
Menu